Actinogen Medical Ratios and Metrics

Market cap in millions EUR. Fiscal year is July - June.

Millions EUR. Fiscal year is Jul - Jun.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb '26 Feb 23, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Market Capitalization	87	41	104	44	59	137
Market Cap Growth	48.36%	-60.62%	133.88%	-25.15%	-56.65%	806.03%
Enterprise Value	79	28	96	36	45	129
Last Close Price	0.02	0.01	0.04	0.01	0.02	0.06
PS Ratio	28.47	13.31	16.75	14.86	24.67	108.80
PB Ratio	8.53	3.99	8.45	5.42	4.13	12.37
P/TBV Ratio	9.44	4.41	9.45	6.61	4.72	14.97
EV/Sales Ratio	24.07	9.20	15.60	11.93	18.61	102.47
Debt / Equity Ratio	0.18	0.18	0.02	0.01	0.01	0.01
Net Debt / Equity Ratio	-0.72	-0.72	-0.46	-0.62	-0.74	-0.76
Net Debt / EBITDA Ratio	0.88	0.88	0.71	0.79	1.76	3.67
Net Debt / FCF Ratio	1.74	1.74	0.54	0.96	1.70	7.64
Asset Turnover	0.24	0.24	0.54	0.25	0.18	0.13
Quick Ratio	3.74	3.74	13.83	6.99	13.73	19.87
Current Ratio	3.76	3.76	13.91	7.04	13.80	19.99
Return on Equity (ROE)	-77.47%	-77.47%	-78.81%	-61.18%	-48.46%	-27.62%
Return on Assets (ROA)	-41.91%	-41.91%	-45.37%	-35.65%	-28.59%	-16.16%
Return on Capital Employed (ROCE)	-82.90%	-82.90%	-66.40%	-81.90%	-43.70%	-22.20%
Earnings Yield	-9.42%	-20.16%	-7.84%	-14.80%	-10.58%	-1.81%
FCF Yield	-4.86%	-10.39%	-10.20%	-12.02%	-10.60%	-0.80%
Buyback Yield / Dilution	-37.04%	-37.04%	-20.69%	-4.92%	-22.20%	-25.69%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.